AC Immune
ACIU
64 hedge funds and large institutions have $118M invested in AC Immune in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 8 closing their positions.
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
87% more call options, than puts
Call options by funds: $1.82M | Put options by funds: $976K
17% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 18
12% more funds holding
Funds holding: 57 → 64 (+7)
0.73% less ownership
Funds ownership: 25.04% → 24.31% (-0.73%)
18% less capital invested
Capital invested by funds: $144M → $118M (-$25.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$6.9M |
| 2 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$4.55M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.38M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.84M |
| 5 |
Morgan Stanley
New York
|
+$2.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$13.6M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$11.5M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.56M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.06M |
| 5 |
Two Sigma Investments
New York
|
-$961K |
ACIU Hedge Fund Activity: Q3 2021 in Review
64 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2021, worth a combined $118M — down 18% from $144M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new ACIU positions and 8 closed out — a net gain of 7 holders — while 21 added to existing stakes and 18 trimmed.
The largest buyer was Suvretta Capital Management, opening a new position worth an estimated $6.9M. The largest seller was EcoR1 Capital, cutting an estimated $13.6M.
- 64 institutional investors held AC Immune (ACIU) as of Q3 2021, up from 57 in Q2 2021.
- Funds reported $118M of AC Immune stock for Q3 2021, down 18% quarter-over-quarter.
- 15 funds opened new AC Immune positions in Q3 2021 and 8 closed out, a net change of +7 holders.
- The largest AC Immune buyer in Q3 2021 was Suvretta Capital Management, an estimated $6.9M added.
- The largest AC Immune seller in Q3 2021 was EcoR1 Capital, an estimated $13.6M sold.
Based on aggregated 13F filings for Q3 2021.